Načítá se...
Bevacizumab treatment in the elderly patient with metastatic colorectal cancer
Metastatic colorectal cancer (mCRC), like many cancers, is primarily a disease of elderly people. Despite this prevalence, such patients are often excluded from randomized trials or represent a minority of enrolled patients. Moreover, the criteria for establishing benefit or side effects of treatmen...
Uloženo v:
| Vydáno v: | Clin Interv Aging |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289484/ https://ncbi.nlm.nih.gov/pubmed/25584021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S54675 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|